DongKook Pharmaceutical Dividends and Buybacks
Dividend criteria checks 2/6
DongKook Pharmaceutical is a dividend paying company with a current yield of 1.11% that is well covered by earnings.
Key information
1.1%
Dividend yield
0.01%
Buyback Yield
| Total Shareholder Yield | 1.1% |
| Future Dividend Yield | 1.1% |
| Dividend Growth | 12.5% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₩180.000 |
| Payout ratio | 13% |
Recent dividend and buyback updates
Recent updates
DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Investors Are Less Pessimistic Than Expected
Aug 07
These 4 Measures Indicate That DongKook Pharmaceutical (KOSDAQ:086450) Is Using Debt Reasonably Well
May 29We Think DongKook Pharmaceutical (KOSDAQ:086450) Can Stay On Top Of Its Debt
May 06DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 06How Much Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Do Insiders Own?
Mar 15The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Has Gained 136%, So Why Not Pay It Some Attention?
Feb 28DongKook Pharmaceutical Co., Ltd.'s (KOSDAQ:086450) Stock Is Going Strong: Is the Market Following Fundamentals?
Feb 14
DongKook Pharmaceutical (KOSDAQ:086450) Seems To Use Debt Quite Sensibly
Feb 01DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jan 19The Attractive Combination That Could Earn DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) A Place In Your Dividend Portfolio
Jan 06DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
Dec 24With EPS Growth And More, DongKook Pharmaceutical (KOSDAQ:086450) Is Interesting
Dec 21What Kind Of Investors Own Most Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)?
Dec 08The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Is Up 177% And Shareholders Are Boasting About It
Nov 23Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, A086450 has been paying a dividend for less than 10 years.
Growing Dividend: A086450's dividend payments have increased, but the company has only paid a dividend for 5 years.
Dividend Yield vs Market
| DongKook Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A086450) | 1.1% |
| Market Bottom 25% (KR) | 1.3% |
| Market Top 25% (KR) | 4.0% |
| Industry Average (Pharmaceuticals) | 1.1% |
| Analyst forecast (A086450) (up to 3 years) | 1.1% |
Notable Dividend: A086450's dividend (1.11%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (1.26%).
High Dividend: A086450's dividend (1.11%) is low compared to the top 25% of dividend payers in the KR market (4.01%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (12.8%), A086450's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (37.1%), A086450's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/28 14:05 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
DongKook Pharmaceutical Co., Ltd. is covered by 10 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mujinn Lee | Cape Investment & Securities Co., Ltd. |
| null null | DBS Bank Ltd |
| Hyuk Jin Yoon | Eugene Investment & Securities Co Ltd. |